Related Experiment Video
Updated: Feb 5, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
Precision Medicine Approaches When Prostate Cancer Akts Up
Tian Zhang1,2, Daniel J George1,2,3, Andrew J Armstrong4,5
1Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina.
Abstract:
Ipatasertib combined with abiraterone in PTEN-null prostate cancer improved progression-free survival in a randomized phase II study of patients with metastatic castration-resistant prostate cancer (mCRPC), providing clinical evidence of reciprocal activation between the Akt and androgen receptor (AR) pathways. These data revive the rationale for targeting PTEN loss in prostate cancer.See related article by de Bono et al., p. 928.
Related Concept Videos
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
Uncertainty in Measurement: Accuracy and Precision
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs Acting on Autonomic Ganglia: Blockers
Microorganisms in Medicine and Therapeutics

